Tenascin-X is a Novel Diagnostic Marker of Malignant Mesothelioma
Authors:
- 1 November 2009
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 33 (11) , 1673-1682
Abstract
Tenascin XB (TNXB) was previously identified as a gene that is more highly expressed in malignant mesothelioma compared with ovarian/peritoneal serous carcinoma based on gene expression array analysis. The objective of this study was to validate this finding at the mRNA and protein levels. Effusions (n=91; 71 ovarian carcinomas, 10 breast carcinomas, and 10 malignant mesotheliomas) were assayed for TNXB mRNA expression using quantitative polymerase chain reaction. Tenascin-X protein expression was studied in 183 effusions (137 carcinomas of different origin, 37 mesotheliomas, and 9 reactive effusions) and 178 solid lesions (122 ovarian/peritoneal carcinomas and 56 mesotheliomas) using immunohistochemistry. Quantitative polymerase chain reaction analysis showed significantly higher TNXB mRNA level in mesotheliomas compared with ovarian and breast carcinomas (PPP<0.001). Our data suggest that tenascin-X may be a new diagnostic marker of malignant mesothelioma in the differential diagnosis of cancers involving the serosal cavities, particularly in the differential diagnosis between this tumor and ovarian/peritoneal serous carcinoma.Keywords
This publication has 22 references indexed in Scilit:
- The regulation of tenascin expression by tissue microenvironmentsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- The Diagnostic Role of Claudins in Serous EffusionsAmerican Journal of Clinical Pathology, 2007
- Applications and Limitations of Immunohistochemistry in the Diagnosis of Malignant MesotheliomaAdvances in Anatomic Pathology, 2006
- Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal MesotheliomaClinical Cancer Research, 2006
- Podoplanin: A Novel Diagnostic Immunohistochemical MarkerAdvances in Anatomic Pathology, 2006
- Value of Immunohistochemistry in Distinguishing Peritoneal Mesothelioma From Serous Carcinoma of the Ovary and PeritoneumAdvances in Anatomic Pathology, 2006
- Meet the Tenascins: Multifunctional and MysteriousJournal of Biological Chemistry, 2005
- Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer programLeukemia, 2003
- The Role of Desmin and N-Cadherin in Effusion CytologyAmerican Journal of Surgical Pathology, 2001
- Immunocytochemistry in effusion cytologyCancer, 2001